Last reviewed · How we verify
Treatment of bronchospasm occurring during anesthesia
Approved treatments
- ISOPROTERENOL
Isoproterenol activates beta-adrenergic receptors without affecting alpha-adrenergic receptors.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Treatment of bronchospasm occurring during anesthesia patent landscape — cliff calendar, originator estates, attackable patents
- Treatment of bronchospasm occurring during anesthesia treatment landscape brief
- Treatment of bronchospasm occurring during anesthesia treatment updates RSS
Frequently asked questions about Treatment of bronchospasm occurring during anesthesia
What drugs treat Treatment of bronchospasm occurring during anesthesia?
Tracked treatments include ISOPROTERENOL.
What is the treatment for Treatment of bronchospasm occurring during anesthesia?
Standard treatment for Treatment of bronchospasm occurring during anesthesia includes ISOPROTERENOL. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Treatment of bronchospasm occurring during anesthesia patent cliff · Treatment of bronchospasm occurring during anesthesia CI report
- Treatment: ISOPROTERENOL
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing